Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chronocort vs Plenadren in Adrenal Insufficiency
NCT05222152Phase 2Completed
- Sponsor
- Neurocrine Biosciences
- Start
- Nov 2021
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of hydrocortisone modified-release in primary adrenal insufficiency (PAI), sponsored by Neurocrine Biosciences. Started Nov 2021; status: completed.
02
Drugs
hydrocortisone modified-release
03
Conditions
primary adrenal insufficiency (PAI)
Beyond the preview
Go deeper on NCT05222152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05222152.